Consistent with the sensitivity of BCL-2 overexpressing MCF10A cells to ABT-737, we found that B-cell lymphoma cells with relatively high BCL-2 levels (SP53 and JeKo-1 cells) were also ABT-737 sensitive (Fig. 9). This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.